Cargando…

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis

INTRODUCTION: To define the best cutoff of the Glasgow-Blatchford score (GBS) for identifying high- and low-risk rebleeding patients with bleeding ulcers and high-risk stigmata after endoscopic hemostasis and compare the efficacy of high-dose and standard-dose intravenous proton pump inhibitors (HD-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhenhua, Lai, Yongkang, Ouyang, Liu, Lv, Nonghua, Chen, Youxiang, Shu, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810506/ https://www.ncbi.nlm.nih.gov/pubmed/33448708 http://dx.doi.org/10.14309/ctg.0000000000000294

Ejemplares similares

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Superiority of urgent vs early endoscopic hemostasis in patients with upper gastrointestinal bleeding with high-risk stigmata
por: Horibe, Masayasu, et al.
Publicado: (2021)

A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding
por: Lu, Lung-Sheng, et al.
Publicado: (2012)

Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023)

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Vonkeman, Harald, et al.
Publicado: (2010)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
por: Wang, Qing, et al.
Publicado: (2014)

Skipping the Drip: Intravenous Proton Pump Inhibitor Bolus Therapy Leads to Poor Outcomes in High-Risk Bleeding
por: Khan, Raja Samir, et al.
Publicado: (2020)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion
por: Cheng, Hsiu-Chi, et al.
Publicado: (2016)

Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials
por: Zhu, Wei, et al.
Publicado: (2022)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
por: Wang, Bi-Yun, et al.
Publicado: (2015)

Optimized high-dose amoxicillin–proton-pump inhibitor dual therapies fail to achieve high cure rates in China
por: Hu, Jia-Li, et al.
Publicado: (2017)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Proton pump inhibitors: Review of reported risks and controversies
por: Brisebois, Simon, et al.
Publicado: (2018)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Clinical outcomes of esophagogastroduodenoscopy in critically ill patients using high-dose proton pump inhibitor for suspected bleeding: A retrospective cohort study
por: Kwack, Won Gun
Publicado: (2021)

Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014)

Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
por: Wang, Bi-Yun, et al.
Publicado: (2015)

Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort
por: Rodríguez-Poncelas, Antonio, et al.
Publicado: (2018)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India
por: Deolekar, Pradnya, et al.
Publicado: (2023)

A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
por: Tang, Jevon, et al.
Publicado: (2021)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis
por: Chen, Yingxi, et al.
Publicado: (2016)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Proton pump inhibitors as a risk factor for norovirus infection
por: PRAG, C., et al.
Publicado: (2017)

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
por: Chaiyana, Parata, et al.
Publicado: (2023)

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
por: Hajiani, Eskandar, et al.
Publicado: (2022)

Comparison of Oral and Intravenous Proton Pump Inhibitor on Patients with High Risk Bleeding Peptic Ulcers: A Prospective, Randomized, Controlled Clinical Trial
por: Mostaghni, A A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dg7qlop40ep4uu04rcdnuibune